Navigation Links
Scientists Activate New Cancer Drug Using Light and Oxygen

Researchers at the Ontario Cancer Institute at Princess Margaret Hospital have successfully proven that cancer cells alone can be killed by a new cancer drug that is triggered by a laser light, a process known as photodynamic therapy (PDT).

In a study published today in the Proceedings of the National Academy of Sciences (PNAS), Dr. Gang Zheng, Senior Scientist - Division of Biophysics and Bioimaging, Joey and Toby Tanenbaum/Brazilian Ball Chair for Prostate Cancer Research - Ontario Cancer Institute, Associate Professor, Medical Biophysics - University of Toronto, and Dr. Brian Wilson, Head - Division of Biophysics and Imaging - Ontario Cancer Institute, Professor - Department of Medical Biophysics - University of Toronto, describe the PDT process that they have collaborated on over three years. The collaboration began before Dr. Zheng was recruited to OCI from the University of Pennsylvania in August 2006.

Their paper describes how these new photosensitizer drugs can only be activated by light once they have been localized in the target tumor cells. For the first time Zheng and Wilson have demonstrated that tumor cells can be selectively attacked using a PDT. When the light activates this new drug, it then works to produce a reactive form of oxygen, which destroys only the cells that have been marked by the cancer-fighting drug, thereby sparing other normal healthy neighboring cells.

The process really is about controlling the drugs ability to produce this reactive form of oxygen, explains Dr. Zheng. For the first time, using mouse models and on separate cells, we have shown that it is possible to limit the collateral damage to surrounding normal cells using this approach.

Clinical trials in patients are still a year or two away.

This is an exciting step in the fight against cancer, said Dr. Wilson. This process should greatly enhance the therapeutic window, making tumors much more suscepti ble for PDT damage than normal cells and tissues.

This study is a follow-up to Dr. Zhengs and Dr. Wilsons 2004 concept paper, published in the Journal of the American Chemical Society, that describes the theory of what they have now proven in the lab.

The Ontario Cancer Institute at Princess Margaret Hospital is one of the world leaders in terms of PDT delivery, said Dr. Christopher Paige, Vice President, Research and Senior Scientist Division of Stem Cell and Developmental Biology, Ontario Cancer Institute. The cooperation between Dr. Zheng and Dr. Wilson, even before Dr. Zheng joined us at OCI, demonstrates the incredible spirit of collaboration that we pride ourselves on at University Health Network.


'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
Breaking Medicine Technology: